Current federal regulations still tie the hands of many researchers who wish to study the effects of cannabis. So what needs to change?
The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.
With over 70 known cannabinoids present in the cannabis plant, it's important that researchers and testing staff look at more than just the THC content when examining cannabis material. But how exactly do analysts profile and study these dozens of cannabinoids?
The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.
According to the new study from Lancet Psychiatry, a promising treatment for cannabis dependence could be right within reach of many cannabis consumers: CBD.
The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.
Discover how analytical testing procedures can often lead to contamination and sources of errors if not adequately addressed.
Sapphire Medical Clinics, one of the few medical cannabis clinics in the UK, has guaranteed the treatment of its first patient for one year.
If given approval, the new regulations could come into effect in a matter of weeks.